Basics Tourmaline Bio, Inc. Common Stock IPO Date: May 3, 2021 Sector: Healthcare Industry: Biotech Market Cap: $775.39M Activated in VL: False Average Daily Range Avg Daily Range: $0.68 | 3.27% Avg Daily Range (30 D): $0.60 | 2.64% Avg Daily Range (90 D): $0.53 | 2.81% Institutional Daily Volume Avg Daily Volume: .22M Avg Daily Volume (30 D): .2M Avg Daily Volume (90 D): .21M Trade Size Avg Trade Size (Sh.): 60 Avg Trade Size (Sh.) (30 D): 51 Avg Trade Size (Sh.) (90 D): 53 Institutional Trades Total Inst.Trades: 315 Avg Inst. Trade: $2.3M Avg Inst. Trade (30 D): $4.19M Avg Inst. Trade (90 D): $3.79M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.84M Avg Closing Trade (30 D): $.67M Avg Closing Trade (90 D): $.97M Avg Closing Volume: 96.59K     News Oct 16, 2025 @ 5:00 PM Thyroid Eye Disease Clinical Trial Pipeline Gains ... Source: Delveinsight Oct 8, 2025 @ 9:51 PM $HAREHOLDER ALERT: The M&A Class Action Continues ... Source: Juan Monteverde Sep 26, 2025 @ 5:15 AM Novartis to showcase transformative data in advanc... Source: Novartis Sep 15, 2025 @ 9:30 PM SHAREHOLDER ALERT: The M&A Class Action Firm Annou... Source: Juan Monteverde Sep 9, 2025 @ 12:10 PM Novartis To Expand Heart Drug Portfolio With $1.4 ... Source: Vandana Singh Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.89 $-.78 $-.68 Diluted EPS $-.89 $-.78 $-.68 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -22.97M $ -20.18M $ -17.49M Operating Income / Loss $ -26.23M $ -24.44M $ -21.97M Cost of Revenue $ $ $ Net Cash Flow $ 4.82M $ -35.14M $ -28.14M PE Ratio